Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B-specific CD4+ T cell responses
Jeffrey R. MaslankaiD, Qianxuan SheiD, Kathleen S KraussiD, Emily Nicole BitskoiD, Nile U. BayardiD, Jennifer LondreganiD, Mohamad‐Gabriel AlamehiD, Laurence Crane EisenlohriD, Michele A. KutzleriD, Joseph P. ZackulariD, Michael C. AbtiD
Abstract
The gastrointestinal pathogen Clostridioides difficile, is a major burden for health systems due to high rates of recurrence. C. difficile pathogenesis is mediated by two virulence factors, toxin A (TcdA) and Toxin B (TcdB). Antibodies specific for TcdA and TcdB are correlated with protection from symptomatic recurrence, however, the role for CD4+ T cells is poorly understood in part due to the lack of tools to study the toxin-specific CD4+ T cell response. Our group recently demonstrated the antibody and CD4+ T cell response to C. difficile toxins is impaired via the glucosyltransferase activity of the toxins; however, tools do not exist to study the protective capacity and the phenotype of toxin-specific CD4+ T cells. Therefore, we developed an MHC-II tetramer to identify TcdB-specific CD4+ T cells via flow cytometry. Herein, we identified an immunodominant epitope (TcdB1961-1975) in the CROPs region of TcdB and optimized an MHC-II tetramer for use in tracking and phenotyping TcdB-specific CD4+ T cell responses following multiple different immunization strategies in mice. Utilizing the tetramer, TcdB-specific T follicular helper (Tfh) cells were detected following TcdB-CROPs mRNA-LNP vaccination validating the advantage of the tetramer. Furthermore, using a modular mRNA vector expressing the TcdB1961 peptide covalently bound to the beta chain of MHC-II (MHC-II{beta}) we were able to generate a robust population of TcdB-specific CD4+ T cells. These data outline the generation of new tools for the C. difficile field and lay the groundwork for future studies of toxin-specific CD4+ T cell responses.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 5.02
- Field percentile
- top 4%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clostridioides difficile toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity
Jeffrey R. Maslanka, Jennifer Londregan, … Michael C. Abt·Mucosal ImmunologyPeer-reviewed·Aug 18, 2025
- Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo
S. L. Kordus, H. K. Kroh, … B. W. Spiller·bioRxiv·Jun 21, 2023
- Receptor-binding domain 2 of Clostridioides difficile binary toxin as a promising vaccine component against C. difficile infection
Shaohui Wang, Joshua Heuler, … Xingmin Sun·bioRxiv·Aug 31, 2026
- Human C. difficile-specific memory B cells encode protective IgG1 despite predominance of non-neutralizing antibodies.
Sydney T. Honold, Kathleen Norris, … Mark L. Lang·bioRxiv·Dec 11, 2025
- Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.
Farha Naz, Nicholas Hagspiel, … Mayuresh M. Abhyankar·npj VaccinesPeer-reviewed·Feb 18, 2025
- Clostridium difficile binary toxin (CDT) is recognized by the TLR2/6 heterodimer to induce an NF-κB response
M. Simpson, A. Frisbee, … W. Petri·bioRxiv·Sep 8, 2020